EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C11H16N2O3 |
| Net Charge | 0 |
| Average Mass | 224.260 |
| Monoisotopic Mass | 224.11609 |
| SMILES | C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O |
| InChI | InChI=1S/C11H16N2O3/c1-4-5-11(6-7(2)3)8(14)12-10(16)13-9(11)15/h4,7H,1,5-6H2,2-3H3,(H2,12,13,14,15,16) |
| InChIKey | UZVHFVZFNXBMQJ-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Applications: | sedative A central nervous system depressant used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| butalbital (CHEBI:102524) has functional parent barbituric acid (CHEBI:16294) |
| butalbital (CHEBI:102524) has role analgesic (CHEBI:35480) |
| butalbital (CHEBI:102524) has role sedative (CHEBI:35717) |
| butalbital (CHEBI:102524) is a barbiturates (CHEBI:22693) |
| IUPAC Name |
|---|
| 5-(2-methylpropyl)-5-(prop-2-en-1-yl)pyrimidine-2,4,6(1H,3H,5H)-trione |
| INNs | Source |
|---|---|
| butalbital | ChemIDplus |
| butalbitalum | ChemIDplus |
| Synonyms | Source |
|---|---|
| 5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione | ChEMBL |
| 5-allyl-5-(2'-methyl-n-propyl) barbituric acid | ChemIDplus |
| 5-allyl-5-isobutylbarbituric acid | ChemIDplus |
| allylbarbitone | NIST Chemistry WebBook |
| allylbarbital | ChemIDplus |
| allylbarbituric acid | ChemIDplus |
| Manual Xrefs | Databases |
|---|---|
| DB00241 | DrugBank |
| D03182 | KEGG DRUG |
| Butalbital | Wikipedia |
| HMDB0014386 | HMDB |
| LSM-5793 | LINCS |
| 441 | DrugCentral |
| Citations |
|---|